Cartesian Therapeutics Correlations

RNAC Stock   7.61  0.03  0.39%   
The current 90-days correlation between Cartesian Therapeutics and Nautilus Biotechnology is 0.06 (i.e., Significant diversification). The correlation of Cartesian Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cartesian Therapeutics Correlation With Market

Good diversification

The correlation between Cartesian Therapeutics and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cartesian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Cartesian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Cartesian Stock refer to our How to Trade Cartesian Stock guide.

Moving together with Cartesian Stock

  0.61DRMA Dermata Therapeutics TrendingPairCorr
  0.65VINC Vincerx Pharma CommonPairCorr
  0.68VYGR Voyager TherapeuticsPairCorr
  0.62REVB Revelation BiosciencesPairCorr

Moving against Cartesian Stock

  0.47HLN Haleon plc Aggressive PushPairCorr
  0.35LYEL Lyell ImmunopharmaPairCorr
  0.34CAPR Capricor TherapeuticsPairCorr
  0.56TRV The Travelers CompaniesPairCorr
  0.49DD Dupont De NemoursPairCorr
  0.45VZ Verizon Communications Earnings Call This WeekPairCorr
  0.39JPM JPMorgan ChasePairCorr
  0.32BAC Bank of AmericaPairCorr
  0.32JNJ Johnson JohnsonPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GNFTAARD
AARDEPRX
OBIONAUT
GNFTIVA
GNFTEPRX
NAUTEPRX
  

High negative correlations

FENCNAUT
FENCAARD
FENCEPRX
NTHINAUT
FENCOBIO
MDWDIVA

Risk-Adjusted Indicators

There is a big difference between Cartesian Stock performing well and Cartesian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cartesian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EPRX  2.97  0.66  0.21  0.55  2.79 
 6.98 
 24.61 
IVA  3.69  0.57  0.09  1.12  5.27 
 9.41 
 21.06 
NAUT  5.50  0.87  0.12 (2.13) 5.56 
 15.08 
 53.15 
OBIO  3.75 (0.05) 0.01  0.05  3.98 
 10.17 
 19.34 
MDWD  1.85 (0.04)(0.03)(0.01) 2.64 
 3.79 
 14.07 
AARD  3.91  0.25  0.08  0.15  4.30 
 9.25 
 36.39 
FENC  2.05 (0.18) 0.00 (0.44) 0.00 
 4.19 
 17.84 
AVTX  3.62 (0.10) 0.00 (0.12) 0.00 
 6.93 
 25.25 
NTHI  5.47 (0.04) 0.03  0.06  7.60 
 9.99 
 41.97 
GNFT  3.32  0.76  0.12 (0.77) 3.97 
 8.47 
 25.18 

Cartesian Therapeutics Corporate Management

Emily EnglishSVP ManufacturingProfile
Peter MDChief OfficerProfile
Milos MDChief OfficerProfile
June SeymourChief OfficerProfile
Blaine DavisChief OfficerProfile
Matthew JDGeneral SecretaryProfile
Metin MDChief OfficerProfile